EP3411062
USE OF CD24 PROTEINS FOR TREATING LEPTIN-DEFICIENT CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.2.2017EP published:
25.11.2020EP application number:
17748111.6
EPO information:
European Patent Register
Max expiry date:
1.2.2037
Title:
USE OF CD24 PROTEINS FOR TREATING LEPTIN-DEFICIENT CONDITIONS
Timeline
Today
2.2.2017EP application
25.11.2020EP Publication
Owner
Name:
Oncoimmune Inc.Address:
9430 Key West Avenue Suite 113, Rockville, Maryland 20850, US
Inventor
Name:
LIU, YangAddress:
Baltimore, MD 20202, US
Name:
ZHENG, PanAddress:
Baltimore, MD 20202, US
Name:
DEVENPORT, MartinAddress:
Gaithersburg Maryland 20878, US
Priority
Number:
201662290202 PDate:
2.2.2016Country:
US
Classification
Categories:
A61K 38/17, A61K 38/22, A61K 47/68, C07K 14/44, C07K 14/195, A61P 5/00